Epigenetic silencing and pharmacological inhibition of EIF5A2 foster venetoclax sensitivity in acute myeloid leukaemia
British Journal of Haematology · 2026
DOI: 10.1111/bjh.70339 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2026. Verfasst von Eva Crespo-García und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain. Hauptthemen laut MEDLINE: Sulfonamides, Bridged Bicyclo Compounds, Heterocyclic, Leukemia, Myeloid, Acute, Peptide Initiation Factors. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Secretariat for Universities and Research of the Ministry of Business and Knowledge of the Government of Catalonia, The Agencia Estatal de Investigacion, Spain, Cellex Foundation.
Abstract (Originalsprache)
We show how the loss of activity of the translation initiation factor EIF5A2-either through gene hypermethylation or pharmacologic inhibition of its highly specific hypusine post-translational modification-induces venetoclax sensitivity in acute myeloid leukaemia (AML) cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.
- Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.
- Department of Biosciences, Faculty of Science, Technology and Engineering, University of Vic-Central University of Catalonia (UVic-UCC), Vic, Barcelona, Spain.
- Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
- Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain.
- Cancer Epigenetics Group, Sant Pau Research Institute (IRSantPau), Barcelona, Spain.
ORCID-Profile: Aleix Noguera-Castells, Laura Martinez-Verbo, Manel Esteller
Förderung
- Secretariat for Universities and Research of the Ministry of Business and Knowledge of the Government of Catalonia
- The Agencia Estatal de Investigacion, Spain
- Cellex Foundation
- 'la Caixa' Foundation
- Ministry of Science, Innovation and Universities, Spain
- Fundación Cellex
Zitieren
APA
Crespo-García, E., Quero-Dotor, C., Noguera-Castells, A., Sancho-Vila, L., Martinez-Verbo, L., & Esteller, M. (2026). Epigenetic silencing and pharmacological inhibition of EIF5A2 foster venetoclax sensitivity in acute myeloid leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.70339
Vancouver
Crespo-García E, Quero-Dotor C, Noguera-Castells A, Sancho-Vila L, Martinez-Verbo L, Esteller M. Epigenetic silencing and pharmacological inhibition of EIF5A2 foster venetoclax sensitivity in acute myeloid leukaemia. British Journal of Haematology. 2026. doi:10.1111/bjh.70339
BibTeX
@article{CrespoGarca2026,
author = {Crespo-García, Eva and Quero-Dotor, Carlos and Noguera-Castells, Aleix and Sancho-Vila, Laia and Martinez-Verbo, Laura and Esteller, Manel},
title = {Epigenetic silencing and pharmacological inhibition of EIF5A2 foster venetoclax sensitivity in acute myeloid leukaemia},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70339}
}
EUVIMED